Jeffrey I. Blankman



  • J.D., Rutgers University School of Law, Camden;
    Ph.D., Chemistry, The University of Maryland, College Park;
    B.A., Chemistry, Franklin & Marshall College.
  • Admitted to the NJ and PA bars
  • Registered with the U.S. Patent and Trademark Office.

More Detail:

Jeff’s practice centers around patent drafting and prosecution, opinions and analysis and managing intellectual property portfolios. Jeff focuses his practice on patents in chemistry, materials science, semiconductor devices and manufacturing, complex equipment, light emitting diodes, textiles, medical devices and pharmaceuticals. Jeff assists clients in developing patent portfolio and prosecution strategies and provides IP evaluation and due diligence support.

Jeff joined Servilla Whitney after over eight years of experience in corporate practice with large companies in the pharmaceutical industry. These include divisions of Wyeth (Formerly Wyeth-Ayerst) and Baxter Healthcare. Jeff has had roles in research organizations, advising on intellectual property matters relating to product development.

Jeff’s Ph.D. research at The University of Maryland focused on the electrochemical properties and electron transfer kinetics of heme proteins. Before pursuing a career in patent law, Jeff developed generic drugs as a Research and Development scientist with ESI Lederle, a division of Wyeth-Ayerst. After Baxter Healthcare purchased ESI Lederle from Wyeth, Jeff continued his scientific career as a R&D laboratory manager while attending law school.

Jeff is a member of the Pennsylvania and New Jersey bars and is registered to practice before the United States Patent and Trademark Office.

Outside the office, Jeff enjoys woodworking, golf and spending time with his family.